Sackler Family Agrees to $6.5 Billion Opioid Settlement
The Sackler family, owners of Purdue Pharma, have agreed to increase their financial contribution to a new bankruptcy settlement for opioid lawsuits to approximately $6.5 billion, up from a previous agreement of $6 billion. This development was reported by the Wall Street Journal.
The Sackler family, known as the proprietors behind Purdue Pharma, has agreed to enhance their financial contribution in a fresh bankruptcy settlement aimed at resolving opioid lawsuits.
According to reports by the Wall Street Journal, the tentative increase in the family's contribution is from $6 billion to roughly $6.5 billion.
This agreement signifies a critical step forward in addressing the multiple opioid-related claims that Purdue Pharma faces.
(With inputs from agencies.)
ALSO READ
Punjab Extends Tax Settlement Scheme Deadline, Providing Relief to Traders
Coffee Day Enterprises Secures Major Debt Settlement with Axis Bank
German Prosecutors Drop Investigation on Russian Oligarch After Settlement
Zia's contributions towards development of Bangladesh, and India-Bangladesh relations, will always be remembered: PM Modi.

